Genpact Limited: valuation
What the market value assumes, and what the company's own statements and its peers' prices would put it at. Every assumption is yours to change.
Cash-flow value and what the price assumes
Average of FY2023–FY2025 (cash from operations less capital spending), from the statements below.
Starts at revenue growth over the last three years, 5.1% a year (statements).
US Treasury 10-year yield on Nov 20, 2026: 4.92% (US Treasury).
Your assumption: the extra yearly return you want for holding shares rather than Treasuries. 5% is a round starting figure, not data.
Your assumption: long-run growth, usually near inflation. It must stay below the discount rate.
Debt less cash at the end of FY2025 (statements); negative means more cash than debt.
What today's price assumes
A market value of $6.6 B means free cash flow growing 1.4% a year for 10 years, then 2.5% for ever, at a 9.92% discount rate.
Revenue grew 5.1% a year over the last three years.
Against the market value, for other rates
Cash-flow value of the shares as a percentage above or below today's market value; your inputs in the middle.
| Discount rate ↓ / growth → | 0.14% | 2.64% | 5.14% | 7.64% | 10.14% |
|---|---|---|---|---|---|
| 7.92% | +26% | +55% | +91% | +134% | +187% |
| 8.92% | +5% | +29% | +58% | +93% | +136% |
| 9.92% | -10% | +10% | +35% | +64% | +99% |
| 10.92% | -21% | -4% | +16% | +41% | +71% |
| 11.92% | -30% | -15% | +2% | +24% | +49% |
On one scale
Bars: from the 25th to the 75th percentile multiple of the peers, the line at the median; dot: the cash-flow value with your inputs.
Your own DCF model
A full discounted-cash-flow model of Genpact Limited, started from its filings: revenue growth and margins year by year, bear, base and bull cases, the WACC and its parts, sensitivity tables and a value per share against the dated market price. Save it, share it with your team or by a read-only link.
Open the DCF modelAgainst the industry Information Technology Services
Multiples of its companies with a market value at most 60 days old, times Genpact Limited's own figures of FY2025.
| Multiple | Peers (25th / median / 75th) | Genpact Limited | Applied to | Value (25th to 75th) | Companies |
|---|---|---|---|---|---|
| P/E | 15.5× / 20.3× / 26.6× | 11.1× | net income $552 M | $8.6 B to $14.7 B | 56 |
| Price to sales | 0.8× / 1.8× / 3.0× | 1.2× | revenue $5.1 B | $3.9 B to $15.4 B | 68 |
| Price to book | 1.9× / 3.6× / 5.9× | 2.6× | book equity $2.5 B | $4.8 B to $15.1 B | 65 |
Peers' multiples from the distributions by industry; the company's figures from its statements below. A multiple says what similar companies cost, not what this one is worth.
Against its own history
Genpact Limited's multiples at each month end with a market cap on file, Jan 2020 to Oct 2026, each against its own median.
P/E
11.3×Now below its median of 14.1×, in the bottom quarter of its range; range 8.4× to 31.9× over 30 months.
Price to sales
1.3×Now below its median of 1.6×, in the bottom quarter of its range; range 0.9× to 2.8× over 30 months.
Price to book
2.6×Now below its median of 3.3×, in the bottom quarter of its range; range 1.9× to 6.0× over 30 months.
as of Oct 28, 2026. Market caps: the dated values on file since 2020, and in between the SEC's fails-to-deliver closing price times the share count on the latest 10-K or 10-Q cover. Each month divides by the last twelve months' results that had been published by then (a quarter 45 days after it ended, a fiscal year 60 days after), so the past is not read with figures that came out later; months with a loss give no P/E. Newest month: Oct 28, 2026.
The statements it starts from
USD millions at each year's exchange rate; free cash flow = cash from operations less capital spending.
| Fiscal year | Revenue | Net income | Cash from operations | Capital spending | Free cash flow | Net debt | Source |
|---|---|---|---|---|---|---|---|
| FY2025to Dec 31, 2025 | $5.1 B | $552 M | $813 M | $78 M | $735 M | $688 M | SEC annual report (10-K, 20-F) |
| FY2024to Dec 31, 2024 | $4.8 B | $514 M | $615 M | $83 M | $533 M | $573 M | SEC annual report (10-K, 20-F) |
| FY2023to Dec 31, 2023 | $4.5 B | $631 M | $491 M | $55 M | $435 M | $673 M | SEC annual report (10-K, 20-F) |
| FY2022to Dec 31, 2022 | $4.4 B | $353 M | $444 M | $51 M | $393 M | $629 M | SEC annual report (10-K, 20-F) |
| FY2021to Dec 31, 2021 | $4.0 B | $369 M | $694 M | $53 M | $641 M | $756 M | SEC annual report (10-K, 20-F) |
| FY2020to Dec 31, 2020 | $3.7 B | $308 M | $584 M | $70 M | $514 M | $660 M | SEC annual report (10-K, 20-F) |
Each figure as filed; the full statements with every line and its filing are on the company page. Market value $6.6 B on Oct 28, 2026.
How it is worked out: the cash-flow value is free cash flow grown at the first-stage rate for the years chosen, then at the long-run rate for ever, each year discounted at the risk-free rate plus the equity risk premium, less net debt. What the price assumes is the first-stage growth that makes that value equal today's market value. The starting cash flow, growth and net debt come from the statements; the risk-free rate from the US Treasury; the premium and the long-run growth are assumptions and are labelled so. This is arithmetic on reported figures, not advice.